AIRLINK 73.50 Decreased By ▼ -0.50 (-0.68%)
BOP 4.99 Decreased By ▼ -0.03 (-0.6%)
CNERGY 4.43 Increased By ▲ 0.01 (0.23%)
DFML 39.11 Decreased By ▼ -0.09 (-0.23%)
DGKC 85.51 Decreased By ▼ -0.58 (-0.67%)
FCCL 21.65 No Change ▼ 0.00 (0%)
FFBL 33.93 Decreased By ▼ -0.08 (-0.24%)
FFL 9.79 Decreased By ▼ -0.13 (-1.31%)
GGL 10.57 Increased By ▲ 0.01 (0.09%)
HBL 113.12 Decreased By ▼ -0.77 (-0.68%)
HUBC 135.90 Increased By ▲ 0.06 (0.04%)
HUMNL 11.99 Increased By ▲ 0.09 (0.76%)
KEL 4.75 Decreased By ▼ -0.09 (-1.86%)
KOSM 4.51 Decreased By ▼ -0.02 (-0.44%)
MLCF 38.20 Decreased By ▼ -0.07 (-0.18%)
OGDC 135.60 Increased By ▲ 0.75 (0.56%)
PAEL 26.00 Decreased By ▼ -0.35 (-1.33%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.75 Increased By ▲ 0.07 (1.05%)
PPL 122.20 Decreased By ▼ -0.80 (-0.65%)
PRL 27.13 Increased By ▲ 0.44 (1.65%)
PTC 14.17 Decreased By ▼ -0.16 (-1.12%)
SEARL 57.52 Decreased By ▼ -1.60 (-2.71%)
SNGP 67.61 Decreased By ▼ -1.89 (-2.72%)
SSGC 10.28 Decreased By ▼ -0.05 (-0.48%)
TELE 8.50 No Change ▼ 0.00 (0%)
TPLP 11.12 Decreased By ▼ -0.11 (-0.98%)
TRG 63.70 Decreased By ▼ -1.15 (-1.77%)
UNITY 26.11 Decreased By ▼ -0.14 (-0.53%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,838 Decreased By -12.7 (-0.16%)
BR30 25,212 Decreased By -124.2 (-0.49%)
KSE100 75,252 Increased By 45.3 (0.06%)
KSE30 24,170 Increased By 27.1 (0.11%)
Markets

Oil falls on coronavirus surge but on track for weekly gain

  • Vaccine unlikely to boost oil demand until well into 2021 –IEA.
  • Higher US crude stocks add to pressure.
  • Brent, WTI on track for second weekly gain.
Published November 13, 2020

LONDON: Oil prices fell on Friday, pressured by fears about a slow recovery in the global economy and fuel demand due to rising coronavirus infections, but hopes for a vaccine kept the market on track for a second straight weekly gain.

Brent crude was down 36 cents, or 0.83%, at $43.17 a barrel as of 1143 GMT. US West Texas Intermediate (WTI) crude futures fell 48 cents, or 1.17%, to $40.64 a barrel.

For the week, both were headed for a surge of about 9%.

US government data also added pressure, as crude inventories rose by 4.3 million barrels last week, compared with an expected fall of 913,000 barrels.

"In essence, some of the feel good factor from the Pfizer vaccine has worn off and disappointing EIA figures have created a bit of a downward correction," Harry Tchilinguirian, head of commodity research at BNP Paribas, said.

"However, OPEC+ is prepared to tweak its production and we're still waiting for the trial results of other vaccines that may be easier to distribute since they won't need such cold storage."

New coronavirus infections in the United States and elsewhere are at record levels and tightening restrictions to contain the spread have dampened the prospect of a near-term end to the global health crisis.

Hopes were high that a resolution to the pandemic is on the horizon - stoking this week's jump in WTI and Brent contracts - after data showed an experimental COVID-19 vaccine being developed by Pfizer Inc and Germany's BioNTech was 90% effective.

The International Energy Agency (IEA), however, said on Thursday that global oil demand is unlikely to get a significant boost from any roll-out of COVID-19 vaccines until well into 2021.

"Views that it would take time to see any benefit from a COVID-19 vaccine prompted investors to unwind their long positions," said Kazuhiko Saito, chief analyst at commodities broker Fujitomi Co.

Chart analysis suggests WTI is headed toward $39.50 a barrel, he added.

Analysts say tougher restrictions on mobility to deal with sky-rocketing coronavirus cases mean the Organization of the Petroleum Exporting Countries (OPEC) and its allies, known as OPEC+, may hesitate to implement a planned loosening of output curbs agreed in a deal earlier this year.

Algeria's energy minister said this week that OPEC+ could extend the group's current oil production cuts into 2021 or deepen them further if required.

Comments

Comments are closed.